Consistent with the upregulation of SAA1 and SAA2 in lung cancer, a decreased level of Apo A-1, an APRP responsible for endogenous cholesterol removal from tissues, was observed in sera of adenocarcinoma patients with respect to healthy donors [13]. This evidence concerns the gene SAA2 and lung cancer.